Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Patrizia, Pellegrini"'
Autor:
Marta Piras, Martina Panebianco, Matteo Garibaldi, Michela Roberto, Gioia Merlonghi, Patrizia Pellegrini, Paolo Marchetti
Publikováno v:
Current Oncology, Vol 28, Iss 3, Pp 1957-1961 (2021)
Introduction. Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) mainly characterized by subacute muscle weakness and skin rash sometimes associated with malignancy. Case Presentation. A 61-year-old female was admitted to our hospital
Externí odkaz:
https://doaj.org/article/d94e774ac4754c1c91b8e93a8930f3a0
Autor:
Chantalle Moulton, Elisa Grazioli, Cristina Antinozzi, Cristina Fantini, Claudia Cerulli, Arianna Murri, Guglielmo Duranti, Roberta Ceci, Maria Chiara Vulpiani, Patrizia Pellegrini, Sveva Maria Nusca, Francesco Cavaliere, Simona Fabbri, Paolo Sgrò, Luigi Di Luigi, Daniela Caporossi, Attilio Parisi, Ivan Dimauro
Publikováno v:
Antioxidants, Vol 12, Iss 5, p 1138 (2023)
Breast cancer (BC) is one of the most commonly diagnosed types of cancer in women. Oxidative stress may contribute to cancer etiology through several mechanisms. A large body of evidence indicates that physical activity (PA) has positive effects on d
Externí odkaz:
https://doaj.org/article/a081f972bff14ef28b4020bdfb8d3dd0
Autor:
Cecilia Nisticò, Giuseppe Buono, Maria Agnese Fabbri, Marianna Giampaglia, Francesco Cognetti, Grazia Arpino, Vincenzo Adamo, Diana Giannarelli, Simone Scagnoli, Giuseppina Sarobba, Gianluigi Ferretti, Patrizia Pellegrini, Francesco Schettini, Vito Lo Russo, Simona Pisegna, Michela Palleschi, Simonetta Stani, Giovanna Catania, Mariangela Ciccarese, Alessandra Fabi, Francesca Morelli, Rosalba Rossella, Michelangelo Russillo
Publikováno v:
Cancer Research. 80:P5-11
Background: Several randomized clinical trials clearly demonstrated that adding palbociclib (P) to endocrine therapies (ET), such as letrozole (LT) or fulvestrant (FLV), significantly improves outcome both in first-line/endocrine sensitive and second
Autor:
Alessandra Fabi, Mariangela Ciccarese, Sinome Scagnoli, Michelangelo Russillo, Francesco Schettini, Giuseppe Buono, Vito Lorusso, Katia Cannita, Grazia Arpino, Simonetta Stani, Michela Palleschi, Rosalba Rossello, Giuseppina Sarobba, Agnese Fabbri, Marianna Giampaglia, Patrizia Pellegrini, Vincenzo Adamo, Francesca Morelli, Vittoria Barberi, Gianluigi Ferretti, Giovanna Catania, Simona Pisegna, Francesco Cognetti, Diana Giannarelli
Publikováno v:
Oncology.
Background: To date, a consensus has not yet been reached about the therapy sequence after disease progression (PD) on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer (MBC). Objectives: The present study assesses, in a real-worl
Autor:
Giorgio Solfanelli, Giulia Bianchini, Mattia Petrungaro, Simone Reale, Oreste Lanza, Armando Ferrera, Giacomo Tini, Marta Piras, Patrizia Pellegrini, Giuliano Tocci, Allegra Battistoni, Massimo Volpe
Publikováno v:
European Heart Journal Supplements. 23
Aims Cardiovascular (CV) toxicities related to chemotherapy have been reported with increasing frequency. Thus, latest cardio-oncology guidelines focused on the importance of a baseline CV risk assessment before starting a potentially cardiotoxic reg
Autor:
Maria Rosaria Torrisi, Gianluca Stanzani, Adriana Bonifacino, Fabio Libi, Simona Petrucci, Annarita Speranza, Camilla Savio, Valeria Vitale, Claudio Amanti, Antonio Pizzuti, Mattia Falchetto Osti, Maria Piane, Mauro Mattei, Carlo Capalbo, Barbara Campanella, Aldo Germani, Laura De Marchis, Lombardi A, Patrizia Pellegrini, S. Maggi
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 3003, p 3003 (2020)
Journal of Clinical Medicine
Volume 9
Issue 9
Journal of Clinical Medicine
Volume 9
Issue 9
The 5&ndash
10% of breast/ovarian cancers (BC and OC) are inherited, and germline pathogenic (P) variants in DNA damage repair (DDR) genes BRCA1 and BRCA2 explain only 10&ndash
20% of these cases. Currently, new DDR genes have been related
10% of breast/ovarian cancers (BC and OC) are inherited, and germline pathogenic (P) variants in DNA damage repair (DDR) genes BRCA1 and BRCA2 explain only 10&ndash
20% of these cases. Currently, new DDR genes have been related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f03079abed6b8fba55ff3654177e584
http://hdl.handle.net/11573/1442555
http://hdl.handle.net/11573/1442555
Autor:
Michela Roberto, Elsa Iannicelli, Paolo Marchetti, V. Sgroi, Maria Bassanelli, R. Porrini, Patrizia Pellegrini, Agostino Tafuri
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-4 (2018)
Experimental Hematology & Oncology
Experimental Hematology & Oncology
Background Currently, there are no data available on the best choice of treatment in heavily pretreated patients with advanced breast cancer. However, the combination of oral vinorelbine and capecitabine has been demonstrated to be effective and safe
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences immunological mechanisms in health and disease and identifying gender-specific biomarkers could
Externí odkaz:
https://doaj.org/article/e2fa33ad289a46f7ad59a019e6a293d2
Autor:
Silvia Angelini, Valentina Sgroi, Francesca Di Pietro, Giovanna Gentile, Mario Occhipinti, Valentina Sini, Valeria Durante, Lidia Strigari, Andrea Botticelli, Paolo Marchetti, Raffaele Giusti, Patrizia Pellegrini, Alessandro Rossi, Concetta Elisa Onesti, Federica Mazzuca, Bruna Cerbelli, Maurizio Simmaco
Publikováno v:
Anticancer Research. 37:2633-2639
BACKGROUND Taxanes are widely used to treat breast cancer patients. Taxanes are metabolized in human liver by the cytochrome CYP3A and are substrate of ATP-binding cassette multidrug transporters ABCB1. Single-nucleotide polymorphisms (SNPs) in genes
Autor:
Tiziana Del Beato, Luigi Liborio Liberatore, Ida Contasta, Anna Maria Berghella, Antonio Mongelli, Enzo Secinaro, Irma Campitelli, Giancarlo Di Gregorio, Matteo Basta, Fabiana Ciccone, Mauro Domenicucci, Patrizia Pellegrini, Roberto Lattanzio, Nunzia Antonucci, Vincenzo Vittorini, Luca Navarra, Giampaolo Caterino, Marino Silvino
Publikováno v:
Current drug targets
18 (2017): 485–495. doi:10.2174/1389450117666160630173647
info:cnr-pdr/source/autori:Berghella, Anna Maria; Contasta, Ida; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore, Luigi Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; and Pellegrini, Patrizia/titolo:The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy/doi:10.2174%2F1389450117666160630173647/rivista:Current drug targets (Print)/anno:2017/pagina_da:485/pagina_a:495/intervallo_pagine:485–495/volume:18
18 (2017): 485–495. doi:10.2174/1389450117666160630173647
info:cnr-pdr/source/autori:Berghella, Anna Maria; Contasta, Ida; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore, Luigi Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; and Pellegrini, Patrizia/titolo:The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy/doi:10.2174%2F1389450117666160630173647/rivista:Current drug targets (Print)/anno:2017/pagina_da:485/pagina_a:495/intervallo_pagine:485–495/volume:18
The definition of personalized treatments in tumor disease could lead to an improvement of the therapeutic success rate. Therefore, biomarkers are urgently required in order to select the patients that could benefit from adjuvant therapies in the ini